Package 70518-4515-0

{"route": ["ORAL"], "spl_id": "4525a399-448d-9536-e063-6294a90ae924", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["be14624b-7eb9-4e7a-9274-1bb88270ecbe"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4515-0)", "package_ndc": "70518-4515-0", "marketing_start_date": "20251104"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4515-1)", "package_ndc": "70518-4515-1", "marketing_start_date": "20251204"}], "brand_name": "topiramate", "product_id": "70518-4515_4525a399-448d-9536-e063-6294a90ae924", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-4515", "generic_name": "topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA090162", "marketing_category": "ANDA", "marketing_start_date": "20251104", "listing_expiration_date": "20261231"}